home / stock / imgn / imgn news

IMGN News and Press, ImmunoGen Inc. From 05/15/19

Stock Information
Company Name: ImmunoGen Inc.
Stock Symbol: IMGN
Market: NASDAQ
Website: immunogen.com
Menu
IMGN IMGN Quote IMGN Short IMGN News IMGN Articles IMGN Message Board
Get IMGN Alerts

News, Short Squeeze, Breakout and More Instantly...
IMGN - ImmunoGen Announces Mature Data from FORWARD II Expansion Cohort Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Ovarian Cancer

Results to be Presented at 2019 ASCO Annual Meeting Combination Demonstrates Significant Anti-Tumor Activity and Favorable Safety and Tolerability in Platinum-Resistant Disease Findings Support Ongoing Studies of Doublet Combination in Platinum-Agnostic Disease and Triplet in Plat...
IMGN - Midday Gainers / Losers

Gainers : PDS Biotechnology (NASDAQ: PDSB ) +35% . Navios Maritime Holdings (NYSE: NM ) +26% . Cellectar Biosciences (NASDAQ: CLRB ) +21% . Nordic American Tankers (NYSE: NAT ) +14% . Ocean Bio-Chem (NASDAQ: OBCI ) +13% . Genetic Technologies (NASDAQ: GENE ) +13% . Amdocs (NASDAQ: DO...

IMGN - ACB and A among premarket losers

ImmunoGen (NASDAQ: IMGN )  -31% . More news on: ImmunoGen, Inc., Sunworks, Inc., Co-Diagnostics, Inc., Stocks on the move Read more ...

IMGN - ImmunoGen not quite there with mirvetuximab soravtansine NDA; shares down 5% premarket

ImmunoGen (NASDAQ: IMGN ) slips  5%  premarket on light volume in reaction to its announcement that the FDA has recommended a new Phase 3 clinical trial evaluating antibody-drug conjugate mirvetuximab soravtansine in patients with high folate receptor alpha-positive, platinum-res...
IMGN - ImmunoGen Provides Regulatory Update on Mirvetuximab Soravtansine Monotherapy in Ovarian Cancer

Conference Call to be Held at 8:00 a.m. ET Today ImmunoGen, Inc. , (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the United States Food and Drug Administration (FDA) has recommended that the Company con...

IMGN - SBGI, AMG, GIII and ZNH among notable midday movers

Gainers:  Aquantia (NYSE: AQ ) +36% . Sinclair Broadcast (NASDAQ: SBGI ) +28% . Athenex (NASDAQ: ATNX ) +25% . Bridgeline Digital (NASDAQ: BLIN ) +22% . Regulus Therapeutics (NASDAQ: RGLS ) +18% . Ovid Therapeutics (NASDAQ: OVID ) +17% . Daxor Corporation (NYSEMKT: DXR ) +17% ....

IMGN - IMGN, ZYNE among premarket gainers

Aquantia (NYSE: AQ ) +36%  on $452M sale to Marvell. More news on: Aquantia Corp., Ovid Therapeutics Inc., Adaptimmune Therapeutics plc, Stocks on the move, Read more ...

IMGN - Immunogen Inc. (IMGN) CEO Mark Enyedy on Q1 2019 Results - Earnings Call Transcript

Immunogen Inc. (IMGN) Q1 2019 Earnings Conference Call May 3, 2019 08:00 ET Company Participants Sarah Kiely - Director, Investor Relations and Corporate Communications Mark Enyedy - President and Chief Executive Officer Anna Berkenblit - Chief Medical Officer Rich Gregory - Ch...

IMGN - ImmunoGen Q1 top line off 57%; shares down 4% premarket

ImmunoGen ( IMGN ) Q1 results : Revenues: $8.6M (-56.6%); Non-cash royalty revenue: $8.5M (+18.1%); License and milestone fees: $0.08M (-99.3%); R&D support: $0.02M (-95.0%). More news on: ImmunoGen, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, R...

IMGN - ImmunoGen beats by $0.03, misses on revenue

ImmunoGen (NASDAQ: IMGN ): Q1 GAAP EPS of -$0.30 beats by $0.03 . More news on: ImmunoGen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Previous 10 Next 10